Seshadri Swathi, Shokr Hala, Gherghel Doina
Vascular Research Laboratory, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK.
Pharmacy Division, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Biomedicines. 2022 Oct 21;10(10):2669. doi: 10.3390/biomedicines10102669.
This study aimed to investigate macro- and microvascular function parameters and their relationship with known markers of cardiovascular risk in patients with untreated moderate to severe obstructive sleep apnoea (OSA). Fourteen patients with moderate to severe OSA and fourteen controls were included in the present study. General assessments included BMI, systemic blood pressure (BP) and circulating markers for oxidative stress and endothelial function. Additional assessments included 24 h BP and heart rate monitoring, as well as the assessment of heart rate variability. Macro- and microvascular assessments included augmentation index, carotid intima-media thickness, brachial artery flow-mediated dilation, as well as various retinal microvascular function assessments, using the Dynamic Retinal Vessel Analyzer. All participants completed the Short Form Health Survey, Functional Outcomes of Sleep Questionnaire, and Epworth Sleepiness Scale. The results show that, in comparison to controls, BMI (p = 0.003) and AIx (p = 0.025) were significantly higher in the OSA group. There was, however, no significant difference between groups with regard to other measured systemic general, vascular and circulatory parameters (all p > 0.05). Nevertheless, the retinal microvascular function showed various alterations in the OSA patients, including a delayed reaction time in response to flicker (p = 0.047), as well as a decreased dilation amplitude (p = 0.004), dilation slope (p = 0.004), and post-flicker constriction (p = 0.015). In addition, the observed SlopeAD alterations correlated negatively with BMI values only in the OSA group (r = −0.46, p = 0.045). In conclusion, individuals with untreated moderate to severe OSA but without overt CVD, exhibit signs of increased arterial stiffness and retinal microvascular dysfunction, which can be early indicators for future vascular complications.
本研究旨在调查未经治疗的中重度阻塞性睡眠呼吸暂停(OSA)患者的大血管和微血管功能参数及其与已知心血管风险标志物的关系。本研究纳入了14例中重度OSA患者和14例对照者。一般评估包括体重指数(BMI)、全身血压(BP)以及氧化应激和内皮功能的循环标志物。额外评估包括24小时血压和心率监测,以及心率变异性评估。大血管和微血管评估包括增强指数、颈动脉内膜中层厚度、肱动脉血流介导的扩张,以及使用动态视网膜血管分析仪进行的各种视网膜微血管功能评估。所有参与者均完成了简易健康调查问卷、睡眠问卷功能结果和爱泼华嗜睡量表。结果显示,与对照组相比,OSA组患者的BMI(p = 0.003)和增强指数(AIx,p = 0.025)显著更高。然而,在其他测量的全身一般、血管和循环参数方面,两组之间没有显著差异(所有p>0.05)。尽管如此,OSA患者的视网膜微血管功能出现了各种改变,包括对闪烁的反应时间延迟(p = 0.047),以及扩张幅度降低(p = 0.004)、扩张斜率降低(p = 0.004)和闪烁后收缩降低(p = 0.015)。此外,仅在OSA组中观察到的斜率AD改变与BMI值呈负相关(r = -0.46,p = 0.045)。总之,未经治疗的中重度OSA但无明显心血管疾病(CVD)的个体表现出动脉僵硬度增加和视网膜微血管功能障碍的迹象,这可能是未来血管并发症的早期指标。